Skip to main content

Table 3 Associations of SUA concentrations with NAFLD prevalence

From: Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study

SUA levels

Cases/n (%)

Model 1

Model 2

OR

95% CI

P

OR

95% CI

P

Total (n = 7569)

Q1

176/1523 (11.6)

1

  

1

  

Q2

338/1536 (22.0)

2.41

1.97–2.95

< 0.001

1.78

1.41–2.23

< 0.001

Q3

473/1521 (31.1)

4.39

3.61–5.34

< 0.001

2.85

2.27–3.58

< 0.001

Q4

540/1481 (36.5)

6.31

5.16–7.72

< 0.001

3.19

2.52–4.04

< 0.001

Q5

702/15,084 (6.6)

10.92

8.88–13.44

< 0.001

4.34

3.39–5.54

< 0.001

Men (n = 3126)

Q1

98/603 (16.3)

1

  

1

  

Q2

147/646 (22.8)

1.48

1.11–1.97

0.008

1.20

1.01–1.84

0.281

Q3

197/617 (31.9)

2.38

1.80–3.14

< 0.001

1.57

1.14–2.17

0.006

Q4

221/629 (35.1)

2.93

2.22–3.86

< 0.001

1.94

1.41–2.67

< 0.001

Q5

304/631 (48.2)

5.26

4.01–6.90

< 0.001

2.74

2.00–3.76

< 0.001

Women (n = 4443)

Q1

82/873 (9.4)

1

  

1

  

Q2

152/881 (17.3)

2.04

1.53–2.71

< 0.001

1.70

1.24–2.34

0.001

Q3

226/910 (24.8)

3.27

2.48–4.29

< 0.001

2.27

1.67–3.08

< 0.001

Q4

355/878 (40.4)

6.83

5.23–8.91

< 0.001

4.07

3.02–5.48

< 0.001

Q5

447/901 (49.6)

10.19

7.80–13.31

< 0.001

4.60

3.39–6.24

< 0.001

  1. Category of SUA quintiles
  2. For all participants: Q1, < 231 μmol/L; Q2, 231–271 μmol/L; Q3, 272–312 μmol/L; Q4, 313–366 μmol/L; Q5, ≥ 367 μmol/L
  3. For men: Q1, < 278 μmol/L; Q2, 278–317 μmol/L; Q3, 318–355 μmol/L; Q4, 356–402 μmol/L; Q5, ≥ 403 μmol/L
  4. For women: Q1, < 213 μmol/L; Q2, 213–244 μmol/L; Q3, 245–276 μmol/L; Q4, 277–320 μmol/L; Q5, ≥ 321 μmol/L
  5. Model 1: adjusted for age and sex (only for all participants)
  6. Model 2: adjusted for age, sex (only for all participants), BMI, history of cardiovascular related diseases, DBP, serum AST, TG, TC, HDL and FPG